PMV Pharmaceuticals Statistics
Total Valuation
PMVP has a market cap or net worth of $70.98 million. The enterprise value is -$81.05 million.
Important Dates
The next estimated earnings date is Friday, November 7, 2025, before market open.
| Earnings Date | Nov 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PMVP has 52.99 million shares outstanding. The number of shares has increased by 1.95% in one year.
| Current Share Class | 52.99M |
| Shares Outstanding | 52.99M |
| Shares Change (YoY) | +1.95% |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | 3.39% |
| Owned by Institutions (%) | 45.33% |
| Float | 37.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.47 |
| P/TBV Ratio | 0.47 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.52, with a Debt / Equity ratio of 0.01.
| Current Ratio | 12.52 |
| Quick Ratio | 12.26 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -45.57% and return on invested capital (ROIC) is -30.80%.
| Return on Equity (ROE) | -45.57% |
| Return on Assets (ROA) | -29.11% |
| Return on Invested Capital (ROIC) | -30.80% |
| Return on Capital Employed (ROCE) | -64.36% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.72M |
| Employee Count | 47 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -2.12M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.88% in the last 52 weeks. The beta is 1.64, so PMVP's price volatility has been higher than the market average.
| Beta (5Y) | 1.64 |
| 52-Week Price Change | -19.88% |
| 50-Day Moving Average | 1.40 |
| 200-Day Moving Average | 1.25 |
| Relative Strength Index (RSI) | 43.73 |
| Average Volume (20 Days) | 696,492 |
Short Selling Information
The latest short interest is 1.53 million, so 2.88% of the outstanding shares have been sold short.
| Short Interest | 1.53M |
| Short Previous Month | 751,556 |
| Short % of Shares Out | 2.88% |
| Short % of Float | 4.07% |
| Short Ratio (days to cover) | 2.12 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -90.90M |
| Pretax Income | -82.99M |
| Net Income | -80.87M |
| EBITDA | -90.42M |
| EBIT | -90.90M |
| Earnings Per Share (EPS) | -$1.56 |
Full Income Statement Balance Sheet
The company has $142.27 million in cash and $1.02 million in debt, giving a net cash position of $147.29 million or $2.78 per share.
| Cash & Cash Equivalents | 142.27M |
| Total Debt | 1.02M |
| Net Cash | 147.29M |
| Net Cash Per Share | $2.78 |
| Equity (Book Value) | 140.61M |
| Book Value Per Share | 2.65 |
| Working Capital | 133.70M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$70.07 million and capital expenditures -$72,000, giving a free cash flow of -$70.14 million.
| Operating Cash Flow | -70.07M |
| Capital Expenditures | -72,000 |
| Free Cash Flow | -70.14M |
| FCF Per Share | -$1.32 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PMVP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.95% |
| Shareholder Yield | -1.95% |
| Earnings Yield | -122.09% |
| FCF Yield | -105.89% |
Analyst Forecast
The average price target for PMVP is $5.00, which is 273.27% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $5.00 |
| Price Target Difference | 273.27% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -20.25% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |